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Objective: Synthetic vascular grafts, the most common type of permanent dialysis graft used in the United States, are
associated with great morbidity and expense. In this cohort study of patients undergoing hemodialysis and receiving a
new synthetic vascular graft, detailed intraoperative procedural data were examined as predictors of graft dysfunction and
failure.
Methods: A prospective cohort study of patients receiving hemodialysis who had undergone synthetic (polytetrafluoro-
ethylene) graft placement over 41⁄ years were followed up until either the graft was no longer usable, kidney transplan-
tation was performed, the patient died, or the study ended. The principal methods of analysis used were the Kaplan-Meier
method, to compute survival function for primary and secondary graft patency, and Cox proportional hazards regression,
to model associations between predictor variables and graft failure.
Results: Of 284 patients enrolled in the study, 172 patients (61%) had at least one graft-related event, ie, temporary graft
dysfunction or graft failure, during follow-up. Three-year cumulative graft survival was 54% (95% confidence interval,
45%-62%). Using proportional hazards analysis, history of claudication (rate ratio [RR], 2.14 [range, 0.97-4.73]; P 
.06), number of previous permanent grafts (1 graft: RR, 1.49 [range, 0.88-2.51]; 2 or more grafts: RR, 2.85 [range,
1.43-5.69]; P  .01), dialysis dependency at surgery (RR, 2.96 [range, 1.23-7.12]; P  .02), and use of arterial clamps
in construction of the graft (RR, 2.32 [range, 1.14-4.73]; P  .02) were associated with lower survival, even after
accounting for medical history. Type of graft material, ie, Gore-Tex versus other material (RR, 0.28 [range, 0.16-0.50];
P < .01) and use of the axillary vein (RR, 0.61 [range, 0.36- 1.02]; P .06) for the access site were associated with a lower
rate of graft failure. Similar results were found with Poisson analysis of all graft-related events. In addition, acute arterial
anastomosis, ie, arterial angle less than 90 degrees (RR, 0.63 [range, 0.45-0.91]; P  .01) and use of the brachial artery
versus the radial artery (RR, 0.54 [range, 0.33-0.54]; P  .01) were associated with a lower rate of graft-related events.
Conclusion: These findings suggest possible areas for intervention to improve synthetic vascular graft outcome. (J Vasc
Surg 2003;37:1036-42.)
Synthetic vascular grafts account for approximately half
of all permanent grafts placed in patients with incident
end-stage renal disease in the United States.1 Synthetic
grafts are associated with higher rates of failure and com-
plications than are native arteriovenous fistulas, primarily
because of intimal hyperplasia and stenosis at the venous
anastomoses. Although 42% to 60% of synthetic vascular
grafts remain patent at 3 years, many require intervention
to maintain patency to correct stenoses and thromboses.2,3
Only 22% of all synthetic vascular grafts remain patent
without complication 3 years after placement.4 Mainte-
nance of vascular grafts is costly, and complications are
associated with as many as 10% to 15% of all hospitalizations
of patients undergoing hemodialysis.5 In 1997 The Na-
tional Kidney Foundation published the Dialysis Outcome
and Quality Initiative, one goal of which was to increase use
of autogenous fistulas as new access sites.
Despite associated morbidity, use of synthetic vascular
grafts has increased over time in the United States,6,7 with
extraordinarily high use in certain geographic regions.7
Understanding the causes and correlates of hemodialysis
synthetic vascular graft failure is crucial for development of
strategies to reduce morbidity in patients undergoing long-
term hemodialysis. We hypothesized that measurable as-
pects of the surgical techniques used to place grafts are
important determinants of graft function and survival. To
explore this hypothesis, we observed a community-based
cohort of hemodialysis patients from the time of placement
of the graft, examining both surgical and nonsurgical vari-
ables as potential predictors of synthetic graft failure.
METHODS
Patients receiving hemodialysis at five hospitals in the
Delaware Valley in whom synthetic vascular grafts were
placed between January 1, 1990, and June 15, 1994, were
enrolled in the study. Informed consent was obtained at the
time of surgery. Patients were followed up until the graft
was no longer usable, kidney transplantation was per-
formed, the patient died, or the study ended. Graft-related
events were characterized as either permanent graft failure
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or an episode of temporary graft dysfunction. Permanent
graft failure was operationally defined as the need for con-
struction of a new vascular graft. Temporary graft dysfunc-
tion was defined either as need for a radiologic or surgical
procedure to maintain or reestablish patency of the graft or
as graft infection requiring antibiotic therapy. Primary pa-
tency was defined as the time between graft placement and
first revision or procedure required to maintain or restore
patency. Secondary patency was defined as the time be-
tween graft placement and permanent failure of the graft.
Operative data were collected at the time of surgery on
standardized data forms completed by the study surgeons.
Surgical variables examined included side of surgery, artery
(radial, brachial, ulnar, other), vein (cephalic, antecubital,
axillary, basilic, brachial, other), diameters of artery and
vein, type and diameter of graft, diameters of venous and
arterial anastomoses, length of graft implanted, whether
the antecubital space was crossed, graft configuration
(straight vs curved), and type of anastomosis. Operative use
of vessel loops and clamps, suture material, suture tech-
nique (running vs interrupted), use of heparin, and angles
of arterial and venous anastomoses were also recorded. The
arterial or venous angle was obtuse when the direction of
blood flow through the graft differed from the direction of
flow through the vessel by more than 90 degrees. Large
changes in direction of blood flow that occur with obtuse
anastomotic angles were hypothesized to cause turbulent
blood flow and, potentially, early graft dysfunction.
Inpatient and outpatient medical records for study
patients were abstracted to characterize medical history and
clinical course after graft placement, including episodes of
temporary graft dysfunction and failure. Patients were clas-
sified as having hypertension if they were taking antihyper-
tensive medications or were so identified in the medical
record. Patients were classified as having diabetes mellitus if
they used insulin or an oral hypoglycemic agent. Peripheral
vascular disease was defined as a history of claudication or
amputation. Coronary artery disease was defined as a his-
tory of myocardial infarction, coronary artery bypass graft-
ing, or coronary artery angioplasty. Cerebrovascular disease
was defined as a history of cerebrovascular accident or
transient ischemic attack. Thrombophlebitis and pulmo-
nary embolus were grouped as thromboembolic disease.
Duration of previous dialysis was recorded, as was vascular
access history, including number, side, and type of tempo-
rary and permanent access.
Statistical analysis. Failure-time analyses were used
to examine permanent graft failure from any cause and
failure from any cause except infection. The Kaplan-Meier
method8 was used to compute survival functions for pri-
mary and secondary graft patency.
To model associations between predictor variables and
permanent graft failure, Cox proportional hazards regres-
sion analysis was used.9 We first examined the association
between various presurgical variables, including demo-
graphic variables and prevous comorbid conditions, and
permanent graft failure. Data with unadjusted rate ratio
(RR) associated with P  .2 were considered for inclusion
in multivariable models. We then used forward and back-
ward selection strategies to fit our final models. These
modeling activities initially considered only baseline char-
acteristics, including demographics, medical history, and
comorbid conditions. Next we considered procedural fac-
tors, examined individually, conditional both on baseline
characteristics included in the previous step and on the
center at which the surgery was performed. For adding
these variables, we used the same approach as described
above. We checked for departure of the associations be-
tween risk factors and survival from the proportional haz-
ards assumption with log (-log survival) plots and by inclu-
sion of time by risk factor interaction terms. Survival
analyses were performed with Proc Phreg (version 6.12;
SAS, Cary, NC).
To examine associations between predictor variables
and all graft-related events (permanent graft failure or
temporary graft dysfunction), we used Poisson regression
analysis. We accounted for nonindependence of graft-re-
lated events by using generalized estimating equations,10
and implemented this with PROC GENMOD (version
6.12; SAS). Similar variable selection strategies were used
for these models and for proportional hazards models.
We reran all proportional hazards or Poisson models
with data for patients with incident hemodialysis, without
major changes in associations. Therefore results are re-
ported for the complete cohort of patients.
RESULTS
We identified 349 potential study subjects at the time
of vascular access surgery; 299 agreed to participate in the
study and were enrolled. Of these, we excluded 7 patients
from one hospital, because they were too few to permit
stable hospital-specific estimates, and 8 patients in whom
surgery did not involve the radial or brachial arteries. Thus
284 subjects were followed up on average for 16 months
(range, 0-56 months; median, 12 months). Seventy-two
patients (26%) died, and 172 patients (61%) had at least 1
graft-related event (temporary access dysfunction or per-
manent graft failure) during the course of the study. The
total number of graft-related events was 511. Frequency of
graft-related events in each of the 284 subjects is shown in
Fig 1; 18% of patients had only 1 graft-related event during
follow-up, and 43% of patients had more than 1 graft-
related event.
Thrombectomy was used to treat 53.2% of all episodes
of temporary graft dysfunction, compared with 19.6% of
episodes treated with either angioplasty or thrombolysis.
Ninety-two study patients (32%) had permanent graft fail-
ure; in 12 of these patients, permanent graft failure was the
first recorded graft-related event. Estimates of primary and
secondary patency (Kaplan-Meier method) are shown in
Fig 2. Three-year cumulative graft survival was 54% (95%
confidence interval [CI], 45%-62%).
Distribution of demographic variables, comorbid con-
ditions, and medical conditions is presented in Table I. At
surgery, approximately 51% of patients were older than 65
years (mean, 61.7  15.2 years). Sixty-seven percent of
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patients were African American, and 49% were men. We
examined the association of all demographic and intraop-
erative variables and permanent graft failure. Rate of failure
was lower in white patients (unadjusted RR, 0.56; range,
0.34-0.93; P .02) compared with nonwhite patients, and
was higher among patients with a history of claudication
Fig 1. Distribution of number of graft-related events by patient over the study.
Fig 2. Kaplan-Meier curves with standard error of primary and secondary patency.
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(unadjusted RR, 1.84, range, 0.89-3.81; P  .10). Com-
ponents of dialysis history were among the most predictive
characteristics of subsequent permanent graft failure. Rate
of permanent graft failure was 72% higher in patients with
previous hemodialysis via venous catheter (unadjusted RR,
1.72; range, 1.14-2.60; P  .01) and 78% in patients with
end-stage renal disease for longer than 1 year before surgery
(unadjusted RR, 1.78; range, 1.14-2.78; P .01). Rate of
failure was 284% higher in patients with 2 or more previous
permanent access (unadjusted RR, 3.84; range, 2.03-7.26;
P  .01) compared with patients with no previous perma-
nent access. Rate of permanent graft failure was 193%
higher (unadjusted RR, 1.35-6.36; P  .01) in patients
who were dialysis-dependent at the time of graft placement.
Unadjusted results of Poisson regression for all graft-
related events were similar to those from unadjusted pro-
portional hazards analysis. However, precision was higher
and P values were lower, as would be expected from analysis
using all graft-related events. For example, for claudication,
the odds ratio was 1.86 (95% CI, 1.04-3.32; P .04) with
the Poisson model, a similar but more precise finding than
with proportional hazards analysis.
Data for vascular access surgery are described in Table
II. Tapered grafts were used in 97% of subjects. Most grafts
(89%) were tapered 4 to 7. A multivariable proportional
hazards model for permanent graft failure from any cause
(eg, occlusion, infection) is presented in Table III. In
general, patterns in the association of a given presurgical
factor with any permanent graft failure are mirrored in the
association of the factor with noninfective permanent graft
failure. Claudication and more than 1 previous permanent
access was associated with higher failure rate.
Among the recorded aspects of surgical technique, use
of arterial clamps for hemostasis during surgery was associ-
ated with more than twofold higher rate of permanent graft
failure. Use of the axillary vein rather than more distal veins
was associated with lower failure rate. Use of Gore-Tex
rather than other materials, primarily, Impra, was associ-
ated with more than threefold lower rate of permanent
graft failure. Although the rate varied among hospitals,
there was no evidence of interaction between hospital and
any of the other predictors (data not shown). Similar results
were obtained when primary patency was modeled, but
some variables failed to remain significant even though the
rate ratio was in the same direction. Use of the axillary vein
and arterial clamps was not significant with a multivariable
proportional hazards model for primary patency. Results of
a Poisson regression model of any graft-related event,
which permitted consideration of multiple events in some
patients, are given in Table IV. History of claudication
remained associated with higher failure rate, as was history
of previous grafts, whether permanent or temporary. Use of
Gore-Tex was again associated with a 56% lower failure rate
(P  .01). Use of the radial artery was associated with
higher failure rate, and obtuse arterial angle of anastomosis
was associated with a 37% lower failure rate (P  .01).
Table I. Demographics and comorbid conditions and
their relationship to definitive graft failure
Factor
No. of
patients
Demographics
Sex
Male 138
Female 145
Age (y)
50 70
51-65 69
66-73 71
74 71
Race
White 92
Nonwhite 187
Comorbid conditions
Diabetes
Yes 127
No 157
Claudication
Yes 16
No 268
Amputation
Yes 32
No 252
Hypertension
Yes 260
No 24
CABG
Yes 22
No 262
MI
Yes 79
No 205
Stroke
Yes 36
No 248
TIA
Yes 8
No 276
Thrombophlebitis
Yes 8
No 276
Pulmonary embolus
Yes 5
No 279
Dialysis history
Prior hemodialysis via venous catheter
Yes 114
No 170
ESRD for 1 year
Yes 77
No 185
Number of previous permanent grafts
 2 20
1 74
0 190
Dialysis-dependent at time of graft placement
Yes 219
No 43
CABG, Coronary artery bypass grafting; MI, myocardial infarction; TIA,
transient ischemic attack; ESRD, end-stage renal disease.
Numbers do not always add to 284 patients, because of missing data.
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DISCUSSION
This cohort study of patients receiving a new synthetic
vascular graft examined predictors of graft dysfunction and
failure, including detailed intraoperative procedural data.
Type of graft material, acute arterial anastomosis, and use of
axillary vein and brachial artery in construction of the graft
were associated with improved survival even after account-
ing for medical history. In addition, previous vascular dis-
ease represented by claudication, and dialysis history (du-
ration, number of previous accesses) were also associated
with poorer graft survival. This study contributes to our
understanding of surgical characteristics such as graft ma-
terial, type of angle, and vessel selection associated with
poorer graft survival.
A number of our findings are consistent with those
reported by other investigators. The 46% 3-year failure rate
of synthetic grafts we observed is similar to that reported by
Table IV. Multivariable Poisson model for any graft-
related event*†
Variable
Rate ratio (95%
confidence interval) P
Claudication 2.02 (1.29-3.15) 0.01
Previous dialysis via
venous catheter
1.34 (0.94-1.93) 0.11
Number of previous
permanent access
1 1.84 (1.22-2.79) 0.01‡
2 2.31 (1.34-4.00)
Gore-Tex graft
vs other material
0.44 (0.26-0.75) 0.01
Arterial angle 90
degrees
0.63 (0.45-0.91) 0.01
Brachial vs radial
artery used
0.54 (0.33-0.54) 0.01
*Model adjusted for center.
†Graft-related event is any event of temporary graft dysfunction or graft
failure.
‡Value for test of joint significance of both dummy variables indicating
number of previous grafts.
Table II. Frequency of surgical techniques
Factor
No. of
patients
Arterial loops/clamps
Loop and clamp 192
Clamps only 53
No clamp 29
Venous loops/clamps
Loop and clamp 184
Clamps only 38
No clamp 50
Gore-Tex graft
Yes 238
No 43
Graft crosses antecubital
space
Yes 9
No 257
Arterial angle 90
degrees
Yes 184
No 96
Venous angle 90
degrees
Yes 112
No 166
Artery used
Radial 55
Brachial 229
Vein used
Axillary 109
Antecubital 50
Brachial 57
Cephalic/Basilic 66
Graft configuration
Straight 239
Looped 23
Proximal artery
diameter 4 mm
Yes 153
No 124
Distal artery diameter
4 mm
Yes 142
No 137
Arterial anastomosis
diameter 6 mm
Yes 149
No 132
Venous anastomosis
diameter 9 mm
Yes 149
No 124
Graft length (cm)
30 45
20-30 140
20 90
Numbers do not always add to 284 patients, because of missing data.
Table III. Multivariable proportional hazards model for
graft failure*†
Variable
Rate ratio (95%
confidence interval) P
Claudication 2.14 (0.97-4.73) 0.06‡
Number of previous
permanent access
1 1.49 (0.88-2.51) 0.01§
2 2.85 (1.43-5.69)
Dialysis-dependent at
time of surgery
2.96 (1.23-7.12) 0.02
Arterial clamps vs no
clamps
2.32 (1.14-4.73) 0.02
Gore-Tex graft vs
other material
0.28 (0.16-0.50) 0.01
Axillary vein vs
other vessel
0.61 (0.36-1.02) 0.06‡
*Model adjusted for center.
†Graft failure defined as need for construction of a new vascular graft.
‡Note: Variable did not reach conventional P  .05, secondary to power of
the study.
§Value for test of joint significance of both dummy variables indicating
number of previous grafts.
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Tordoir et al,2 Palder et al,3 Albers,11 and Burger et al,12
but higher than that reported by Winsett and Wolma.13
Although some reports have observed inferior graft
survival among patients with diabetes,14 we detected no
association between age, gender, and diabetes with graft
outcome. These findings are consistent with a report from
the US Renal Data System.15 Similarly, the higher rate of
permanent graft failure among patients with a history of
claudication is also consistent with the observation by
Woods et al15 that patients with a history of peripheral
vascular disease in the 10 years preceding end-stage renal
disease were at 24% higher risk for permanent graft failure.
Although literature has focused on creation of algo-
rithms for placement of vascular access16 and development
of a multidisciplinary approach to vascular access care,17
there are scarce published data on intraoperative proce-
dures and their relationship to graft outcome.18 Some
studies,18 but not all,4 have reported that straight arm
grafts were superior to other upper extremity surgical pro-
cedures. From among 23 procedural variables defined a
priori, only clamp use, vessel selection, brand of synthetic
material, and arterial anastomotic angle were associated
with graft survival in our multivariable models. Each of
these attributes suggests possible areas for intervention to
improve graft function.
A number of potential limitations to our study are
noteworthy. First, in this observational study physicians
made decisions about the surgical methods in the clinical
setting and not according to protocol. It is thus possible
that associations between modifiable factors and graft fail-
ure reflect not only the effects of those factors but also the
selection of patients at higher or lower risk from certain
types of surgery. Although we controlled for comorbid
conditions and medical history in multivariable modeling
to control this bias, adjustment for confounding may have
been incomplete. It is possible that surgeons are already
selecting patients away from procedures that may be less
successful, inasmuch as the number of patients in groups
with detrimental material, vessel, and angle type was much
smaller than in the other groups. Second, this study was
performed during a period when intrgraft flow and pressure
monitoring programs were not routinely implemented.
Graft dysfunction, defined by necessity for an intervention
to maintain graft function, may not have been based on
underlying pathophysiologic conditions but on the differ-
ent clinical practices at each center. Thus models used to
explain graft dysfunction might have partially identified
characteristics associated with more aggressive screening
and identification of graft problems short of thrombosis.
To address this concern, we fit separate models for perma-
nent graft failure, which should have been less affected by
clinical practice style.
Contrary to our expectation, we did not detect any
association between failure rate and vessel size, anastomotic
diameter, or graft diameter. It is conceivable that our
analyses lacked sufficient power to detect such differences,
or there may have been imprecise measurement of vessels,
which would also tend to mask associations. Finally, the
association of various presurgical and demographic factors
with permanent graft failure that we found may not be
generalizable to other populations undergoing routine
monitoring of clinical intragraft pressure or flow. There is
evidence that routine use of such monitoring reduces rates
of graft thrombosis.19 Whether these more recent clinical
Fig 3. Angle of vascular anastomosis. A, Acute angle. B, Obtuse angle.
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strategies reduce the rate of permanent graft failure as
defined in this study remains to be determined. Nonethe-
less, the associations with graft dysfunction that we ob-
served are biologically plausible and consistent across dif-
ferent statistical models, leaving little reason to doubt their
relevance in patients receiving these grafts. African Ameri-
can patients are overrepresented compared with national
figures; however, race was not an independent predictor of
outcome.
In conclusion, graft material, acute arterial anastomo-
sis, use of axillary vein and brachial artery in construction of
the graft, and nonuse of arterial clamps were associated with
improved graft survival in models adjusted for medical
history. These findings suggest possible areas for interven-
tion to improve vascular graft outcome in patients receiving
synthetic vascular grafts.
We thank the surgeons at the participating clinical
centers, who recruited patients into our study.
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